Your browser doesn't support javascript.
loading
Sequential P-GEMOX and radiotherapy for early-stage extranodal natural killer/T-cell lymphoma: A multicenter study.
Zhang, Yuchen; Ma, Shuyun; Cai, Jun; Yang, Yu; Jing, Hongmei; Shuang, Yuerong; Peng, Zhigang; Li, Bingzong; Liu, Panpan; Xia, Zhongjun; Xia, Yi; Gao, Yan; Chen, Daoguang; Lin, Jianyang; Li, Qihui; Xu, Shenghua; Xu, Qingyuan; Zhang, Han; Huang, Huiqiang; Cai, Qingqing.
Afiliación
  • Zhang Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Ma S; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Cai J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Yang Y; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Jing H; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Shuang Y; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Peng Z; Department of Lymphadenoma and Head & Neck Medical Oncology, Fujian Provincial Cancer Hospital & Institute, Fuzhou, China.
  • Li B; Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing, China.
  • Liu P; Department of Lymphohematology and Oncology, Jiangxi Cancer Hospital, Nanchang, China.
  • Xia Z; Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Xia Y; Department of Hematology, Second Affiliated Hospital with Suzhou University, Suzhou, China.
  • Gao Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Chen D; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Lin J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Li Q; Department of Hematology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Xu S; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Xu Q; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zhang H; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Huang H; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Cai Q; Department of Lymphadenoma and Head & Neck Medical Oncology, Fujian Provincial Cancer Hospital & Institute, Fuzhou, China.
Am J Hematol ; 96(11): 1481-1490, 2021 11 01.
Article en En | MEDLINE | ID: mdl-34449095
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Polietilenglicoles / Asparaginasa / Protocolos de Quimioterapia Combinada Antineoplásica / Desoxicitidina / Linfoma Extranodal de Células NK-T Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Polietilenglicoles / Asparaginasa / Protocolos de Quimioterapia Combinada Antineoplásica / Desoxicitidina / Linfoma Extranodal de Células NK-T Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2021 Tipo del documento: Article País de afiliación: China